Lead: SIMAVI

WP1 coordinates the management of CVDLINK, ensuring the consortium achieves its goals and produces high quality outputs in accordance with the project’s timeline and budget. This WP also addresses legal and ethical issues arising throughout the project.

Lead: Tampere University

WP2 addresses challenges hindering the adoption of data-driven solutions, such as cultural contexts, incompatible data formats, and privacy and security concerns. This WP defines the needs of end users and translates them into a set of requirements and functionalities for the CVDLINK outputs.

Lead: SIMAVI

WP3 will analyse real-world data sources and prepare a methodology to integrate them into the CVDLINK federated repository. The WP involves tasks related to the design of federated storage, the development of semi-automated data annotation, and the generation of training datasets for the project’s AI tools. Finally, the WP will include tasks to ensure the project’s repository is accessible and adheres to security, privacy, and FAIR principles.

Lead: Technical University Darmstadt

WP4 will develop AI-driven pipelines to enable analysis of signal, image, and –omics data to improve the detection, diagnosis, and treatment of CVDs, as well as a pipeline generator to enable future end users to deploy AI-driven prognostic tools in different contexts. This WP will also focus on enhancing trust in AI in the medical context by embedding the tools with responsible and trustworthy AI principles such as explainability, transparency, bias mitigation, and fairness.

Lead: Trilateral Research

WP5 manages the data produced throughout the project, facilitating joint ownership and data sharing agreements between partners and drafting user and privacy terms for the CVDLINK platform. The leader of this WP also coordinates the completion of all necessary ethical requirements ahead of the validation studies.

Lead: Tampere University Hospital

WP6 is designed to test and validate the CVDLINK platform. Tasks include testing the federated system developed in previous WPs to ensure the platform can perform all the necessary functions, as well as the publication of a guide to help end users adopt the platform. Finally, the WP includes validation studies conducted in five countries to assess the platform’s efficacy in healthcare settings.

Lead: WELLICS

WP7 builds upon the validation studies facilitated under WP6 to perform cost-effective and cost-utility analyses of the CVDLINK platform. The WP also focuses on the sustainability and uptake of the project’s outputs beyond CVDLINK’s end date, considering different business models and strategies to support the future upscale of project outputs.

Lead: Trilateral Research

WP8 focuses on maximising the impact of the CVDLINK project by communicating it to experts, stakeholders, and the general public. Under this WP, CVDLINK will collaborate with similar EU-funded projects to maximise public awareness and uptake of the project work.